Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baicalein Tablets for Influenza Fever
NCT03830684Phase 2Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Feb 2019
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of baicalein in influenza, sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
baicalein
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03830684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830684.